Evidence map›Paper›PMID 40162782›Full record

ArticlemBio2025

Lavinia V Unverdorben, Ali Pirani, Kyle Gontjes, Bridget Moricz, Caitlyn L Holmes, Evan S Snitkin, Michael A Bachman

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. mBio · 2026
    Article
  3. Article
  4. Loss of O-antigen due toScience advances · 2026
    Article
  5. Article
  6. Effective macrophage clearance ofbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lavinia V UnverdorbenDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0003-3618-9194
Ali PiraniDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Kyle GontjesDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Bridget MoriczDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Caitlyn L HolmesDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0001-5818-148X
Evan S SnitkinDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0001-8409-278X
Michael A BachmanDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0003-2507-6987

Funding

University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization statusR01AI125307 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BACHMAN, MICHAEL ABBOTT · 2017 to 2021
$2.6M
Regional genomic epidemiology to identify drivers of resistance, transmission and infection with carbapenem-resistant Klebsiella pneumoniaeR01AI148259 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SNITKIN, EVAN · 2020 to 2023
$2.2M
Defining macrophage defense during Klebsiella pneumoniae bacteremiaK99AI175481 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLMES, CAITLYN LEIGH · 2024 to 2024
$113k
Genome-driven identification of patient and bacterial drivers of resistance to novel beta-lactam/beta-lactamase inhibitor combination therapiesF31AI186288 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GONTJES, KYLE JAMES · 2024 to 2025
$84k
National Institute of Allergy and Infectious Diseases 1F31AI186288National Institute of Allergy and Infectious Diseases 32AI007528National Institute of Allergy and Infectious Diseases K99AI175481National Institute of Allergy and Infectious Diseases R01AI125307National Institute of Allergy and Infectious Diseases R0AI148259NHGRI NIH HHS 5T32HG000040NHGRI NIH HHS T32 HG000040NIAID NIH HHS F31 AI186288NIAID NIH HHS K99 AI175481NIAID NIH HHS R01 AI125307NIAID NIH HHS R01 AI148259NIAID NIH HHS T32 AI007528
6 · The paper itself

Abstract

IMPORTANCE: In hospitalized patients, gut colonization by the bacterial pathogen

Indexed as

Bacterial CapsulesGastrointestinal TractKlebsiella InfectionsKlebsiella pneumoniaeAnimalsDisease Models, AnimalFemaleHumansMiceOperonVirulenceVirulence FactorsVirulence Factorscapsuleevolutionintestinal colonizationKlebsiellalipopolysaccharidemobile genetic elements

Identifiers

PMID40162782
PMCPMC12077207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.